CymitQuimica logo

CAS 794466-70-9

:

Vernakalant

Description:
Vernakalant is a pharmaceutical compound primarily used as an antiarrhythmic agent, specifically for the rapid conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. It is classified as a selective atrial potassium channel blocker, which helps to stabilize the heart's electrical activity. The substance has a unique mechanism of action, targeting specific ion channels in the atria, which distinguishes it from other antiarrhythmic drugs that may affect the ventricles. Vernakalant is typically administered intravenously and is known for its relatively rapid onset of action. Its chemical structure includes a combination of aromatic and aliphatic components, contributing to its pharmacological properties. The compound is generally well-tolerated, but like all medications, it may have side effects, including hypotension and bradycardia. Due to its targeted action and efficacy, Vernakalant represents a significant advancement in the management of atrial fibrillation, providing a therapeutic option that minimizes the risk of ventricular proarrhythmia associated with other antiarrhythmic therapies.
Formula:C20H31NO4
InChI:InChI=1S/C20H31NO4/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3/t16-,17-,18-/m1/s1
InChI key:InChIKey=VBHQKCBVWWUUKN-KZNAEPCWSA-N
SMILES:O(CCC1=CC(OC)=C(OC)C=C1)[C@H]2[C@@H](CCCC2)N3CC[C@@H](O)C3
Synonyms:
  • Vernakalant
  • 3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, (3R)-
  • (3R)-1-[(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.